| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CTMX sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.08M | $6.93M | - | |
| VP | 300.8K | $1.93M | - | |
| CFO | 295.3K | $900.7K | - | |
| Other | 189.4K | $1.22M | - | |
| Other | 100.0K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 2, 2018 | Ray Debanjan | Chief Financial Officer | Sale+OE | 3,000 | $22.56 | $67,680.00 | -33.6% | |
| Jul 2, 2018 | McCarthy Sean A.68 | President and CEO | Sale+OE | 13,052 | $23.42 | $305,707.86 | -13.7% | |
| Jun 1, 2018 | Ray Debanjan | Chief Financial Officer | Sale+OE | 3,000 | $25.93 | $77,793.00 | -33.6% | |
| May 1, 2018 | Ray Debanjan | Chief Financial Officer | Sale+OE | 3,000 | $26.52 | $79,562.10 | -38.8% | |
| May 1, 2018 | McCarthy Sean A.68 | President and CEO | Sale+OE | 19,578 | $26.55 | $519,743.04 | -80.8% | |
| Apr 2, 2018 | Ray Debanjan | Chief Financial Officer | Sale+OE | 3,000 | $28.12 | $84,360.00 | -38.8% | |
| Mar 26, 2018 | Gluck Frederick W | Director | Sell | 5,000 | $31.93 | $159,641.50 | -1.8% | |
| Mar 2, 2018 | Gluck Frederick W | Director | Sell | 16,181 | $30.00 | $485,465.60 | -5.5% | |
| Mar 2, 2018 | Humphrey Rachel | Chief Medical Officer | Sale+OE | 16,160 | $30.00 | $484,800.00 | -34.8% | |
| Mar 2, 2018 | Ray Debanjan | Chief Financial Officer | Sale+OE | 33,000 | $29.99 | $989,694.50 | -87.4% |